Immunosuppressive Treatment in C3 Glomerulopathy: Is it Really Effective?

Publisher： Karger

E-ISSN： 1421-9670|46|2|96-107

ISSN： 0250-8095

Source： American Journal of Nephrology, Vol.46, Iss.2, 2017-07, pp. : 96-107

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Immunosuppressive Treatment in C3 Glomerulopathy: Time to Reconsider Our Approach

By  

American Journal of Nephrology, Vol. 46, Iss. 2, 2017-07 ,pp. : 93-95

Karger

Access to resources Recommend Favorite

Is Nebivolol Really Effective in Preventing Contrast Induced Nephropathy?

By  

Kidney and Blood Pressure Research, Vol. 40, Iss. 5, 2015-0 ,pp. : 533-541

Karger

Access to resources Recommend Favorite

Association of a Novel 3-Amino Acid Deletion Mutation of Apolipoprotein E (Apo E Tokyo) with Lipoprotein Glomerulopathy

By  

Nephron, Vol. 83, Iss. 3, 1999-10 ,pp. : 214-218

Karger

Access to resources Recommend Favorite

A Case of Lipoprotein Glomerulopathy with apoE Chicago and apoE (Glu3Lys) Treated with Fenofibrate

By  

Case Reports in Nephrology and Dialysis, Vol. 7, Iss. 2, 2017-07 ,pp. : 112-120

Karger

Access to resources Recommend Favorite

Second-Line Immunosuppressive Treatment of Childhood Nephrotic Syndrome: A Single-Center Experience

By  

Nephron Extra, Vol. 4, Iss. 1, 2014-01 ,pp. : 8-17

Karger

Access to resources Recommend Favorite